Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral L-arginine Supplementation in Patients With Non-resectable Brain Metastases Treated With Radiation Therapy With Palliative Intent

NCT02844387 is registered in ClinicalTrials.gov with Instituto de Oncología Ángel H. Roffo as lead sponsor.

NCT NCT02844387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02844387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral L-arginine Supplementation in Patients With Non-resectable Brain Metastases Treated With Radiation Therapy With Palliative Intent
Lead sponsor
Instituto de Oncología Ángel H. Roffo
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2004
Completion date
December 31, 2008
Enrollment
70 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable multiple brain metastases